Abbott (ABT) Tops Q2 EPS by 1c, Updates FY EPS Guidance

Abbott (NYSE: ABT) reported Q2 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $6.64 billion versus the consensus estimate of $6.63 billion.

GUIDANCE:

Abbott sees FY2017 EPS of $2.43-$2.53, versus the consensus of $2.47.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c